gabexate has been researched along with Leukemia in 3 studies
Gabexate: A serine proteinase inhibitor used therapeutically in the treatment of pancreatitis, disseminated intravascular coagulation (DIC), and as a regional anticoagulant for hemodialysis. The drug inhibits the hydrolytic effects of thrombin, plasmin, and kallikrein, but not of chymotrypsin and aprotinin.
Leukemia: A progressive, malignant disease of the blood-forming organs, characterized by distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow. Leukemias were originally termed acute or chronic based on life expectancy but now are classified according to cellular maturity. Acute leukemias consist of predominately immature cells; chronic leukemias are composed of more mature cells. (From The Merck Manual, 2006)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sakakura, M | 1 |
| Wada, H | 2 |
| Suzuki, H | 1 |
| Mori, Y | 1 |
| Deguchi, A | 1 |
| Oukubo, I | 1 |
| Tsuda, M | 1 |
| Tanaka, I | 1 |
| Deguchi, K | 1 |
| Shirakawa, S | 1 |
| Minami, N | 1 |
| Taniguchi, N | 1 |
| Kitani, T | 1 |
| Kawagoe, H | 1 |
| Horiuchi, A | 1 |
| Masaoka, T | 1 |
| Yasunaga, K | 1 |
| Okamoto, Y | 1 |
| Ohkubo, A | 1 |
| Yonezawa, T | 1 |
| Nagai, K | 1 |
1 review available for gabexate and Leukemia
| Article | Year |
|---|---|
[Prevention of hemorrhage occurring in patients with leukemia].
Topics: Anticoagulants; Disseminated Intravascular Coagulation; Gabexate; Heparin; Humans; Leukemia; Platele | 2003 |
2 other studies available for gabexate and Leukemia
| Article | Year |
|---|---|
[Treatment of disseminated intravascular coagulation (DIC) or pre-DIC with gabexate mesilate (FOY)].
Topics: Anticoagulants; Disseminated Intravascular Coagulation; Gabexate; Guanidines; Heparin; Humans; Leuke | 1988 |
[Effects of FOY on DIC patients associated with hematological neoplastic disorders. Hanshin Cooperative Study Group of Hematological Disorders].
Topics: Aged; Aged, 80 and over; Anticoagulants; Disseminated Intravascular Coagulation; Drug Evaluation; Fe | 1987 |